MedTrace Logo

Mood Disorders Bladder Cancer

NCT04036877 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 358

Last updated 2024-11-06

No results posted yet for this study

Summary

This is a cross-sectional study evaluating mood disorders in bladder cancer patients and their caregivers across the bladder cancer trajectory

Conditions

Interventions

OTHER

Mood Disorder Assessment

Assess depression, anxiety, HRQOL, and financial toxicity in both bladder cancer patients and their caregivers via telephone survey

Sponsors & Collaborators

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Elizabeth Wulff-Burchfield, MD · University of Kansas Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-19
Primary Completion
2020-01-14
Completion
2021-08-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04036877 on ClinicalTrials.gov